These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 22539598

  • 1. Pro- and antiatherogenic effects of a dominant-negative P465L mutation of peroxisome proliferator-activated receptor-γ in apolipoprotein E-Null mice.
    Pendse AA, Johnson LA, Kim HS, McNair M, Nipp CT, Wilhelm C, Maeda N.
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1436-44. PubMed ID: 22539598
    [Abstract] [Full Text] [Related]

  • 2. Mediator 1 Is Atherosclerosis Protective by Regulating Macrophage Polarization.
    Bai L, Li Z, Li Q, Guan H, Zhao S, Liu R, Wang R, Zhang J, Jia Y, Fan J, Wang N, Reddy JK, Shyy JY, Liu E.
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1470-1481. PubMed ID: 28642237
    [Abstract] [Full Text] [Related]

  • 3. A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages through a peroxisome proliferator-activated receptor gamma-dependent pathway.
    Avallone R, Demers A, Rodrigue-Way A, Bujold K, Harb D, Anghel S, Wahli W, Marleau S, Ong H, Tremblay A.
    Mol Endocrinol; 2006 Dec; 20(12):3165-78. PubMed ID: 16959872
    [Abstract] [Full Text] [Related]

  • 4. Nifedipine induces peroxisome proliferator-activated receptor-gamma activation in macrophages and suppresses the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Ishii N, Matsumura T, Kinoshita H, Fukuda K, Motoshima H, Senokuchi T, Nakao S, Tsutsumi A, Kim-Mitsuyama S, Kawada T, Takeya M, Miyamura N, Nishikawa T, Araki E.
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1598-605. PubMed ID: 20508203
    [Abstract] [Full Text] [Related]

  • 5. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L, Yang X, Li Q, Zeng P, Liu Y, Liu L, Chen Y, Yu M, Ma C, Li X, Li Y, Zhang R, Zhu Y, Miao QR, Han J, Duan Y.
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
    [Abstract] [Full Text] [Related]

  • 6. Calpain inhibitor prevents atherosclerosis in apolipoprotein E knockout mice by regulating mRNA expression of genes related to cholesterol uptake and efflux.
    Liu J, Wang Q, Wei Y, Zhang S, Chai E, Tang F.
    Microvasc Res; 2022 Mar; 140():104276. PubMed ID: 34742813
    [Abstract] [Full Text] [Related]

  • 7. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
    Marleau S, Harb D, Bujold K, Avallone R, Iken K, Wang Y, Demers A, Sirois MG, Febbraio M, Silverstein RL, Tremblay A, Ong H.
    FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174
    [Abstract] [Full Text] [Related]

  • 8. CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages.
    Bujold K, Rhainds D, Jossart C, Febbraio M, Marleau S, Ong H.
    Cardiovasc Res; 2009 Aug 01; 83(3):457-64. PubMed ID: 19377069
    [Abstract] [Full Text] [Related]

  • 9. AIP1 suppresses atherosclerosis by limiting hyperlipidemia-induced inflammation and vascular endothelial dysfunction.
    Huang Q, Qin L, Dai S, Zhang H, Pasula S, Zhou H, Chen H, Min W.
    Arterioscler Thromb Vasc Biol; 2013 Apr 01; 33(4):795-804. PubMed ID: 23413429
    [Abstract] [Full Text] [Related]

  • 10. Lack of association between adiponectin levels and atherosclerosis in mice.
    Nawrocki AR, Hofmann SM, Teupser D, Basford JE, Durand JL, Jelicks LA, Woo CW, Kuriakose G, Factor SM, Tanowitz HB, Hui DY, Tabas I, Scherer PE.
    Arterioscler Thromb Vasc Biol; 2010 Jun 01; 30(6):1159-65. PubMed ID: 20299691
    [Abstract] [Full Text] [Related]

  • 11. Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice.
    Yin M, Liu Q, Yu L, Yang Y, Lu M, Wang H, Luo D, Rong X, Tang F, Guo J.
    J Vasc Res; 2017 Jun 01; 54(3):123-130. PubMed ID: 28448973
    [Abstract] [Full Text] [Related]

  • 12. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y, Sukhanov S, Shai SY, Danchuk S, Tang R, Snarski P, Li Z, Lobelle-Rich P, Wang M, Wang D, Yu H, Korthuis R, Delafontaine P.
    Circulation; 2016 Jun 07; 133(23):2263-78. PubMed ID: 27154724
    [Abstract] [Full Text] [Related]

  • 13. NF-E2-related factor 2 promotes atherosclerosis by effects on plasma lipoproteins and cholesterol transport that overshadow antioxidant protection.
    Barajas B, Che N, Yin F, Rowshanrad A, Orozco LD, Gong KW, Wang X, Castellani LW, Reue K, Lusis AJ, Araujo JA.
    Arterioscler Thromb Vasc Biol; 2011 Jan 07; 31(1):58-66. PubMed ID: 20947826
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fibromodulin deficiency reduces low-density lipoprotein accumulation in atherosclerotic plaques in apolipoprotein E-null mice.
    Shami A, Gustafsson R, Kalamajski S, Krams R, Segers D, Rauch U, Roos G, Nilsson J, Oldberg Å, Hultgårdh-Nilsson A.
    Arterioscler Thromb Vasc Biol; 2013 Feb 07; 33(2):354-61. PubMed ID: 23202368
    [Abstract] [Full Text] [Related]

  • 16. Isoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient Mice.
    Du F, Gesang Q, Cao J, Qian M, Ma L, Wu D, Yu H.
    Int J Mol Sci; 2016 Nov 18; 17(11):. PubMed ID: 27869741
    [Abstract] [Full Text] [Related]

  • 17. Vav Guanine nucleotide exchange factors regulate atherosclerotic lesion development in mice.
    Rahaman SO, Li W, Silverstein RL.
    Arterioscler Thromb Vasc Biol; 2013 Sep 18; 33(9):2053-7. PubMed ID: 23825362
    [Abstract] [Full Text] [Related]

  • 18. Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.
    Nagashima M, Watanabe T, Shiraishi Y, Morita R, Terasaki M, Arita S, Hongo S, Sato K, Shichiri M, Miyazaki A, Hirano T.
    Atherosclerosis; 2010 Sep 18; 212(1):70-7. PubMed ID: 20684826
    [Abstract] [Full Text] [Related]

  • 19. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
    Sontag TJ, Krishack PA, Lukens JR, Bhanvadia CV, Getz GS, Reardon CA.
    Arterioscler Thromb Vasc Biol; 2014 Feb 18; 34(2):262-9. PubMed ID: 24334873
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)γ-DEPENDENT MECHANISM.
    Yu M, Jiang M, Chen Y, Zhang S, Zhang W, Yang X, Li X, Li Y, Duan S, Han J, Duan Y.
    J Biol Chem; 2016 Aug 12; 291(33):16977-89. PubMed ID: 27358406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.